About Acino
Acino is a company based in Zurich (Switzerland) founded in 1836 was acquired by ADQ in September 2021. It operates as a Direct-to-Consumer (D2C), Reseller / Distribution, and Licensing Model. Acino has completed 1 acquisition, including M8 Pharmaceuticals. Acino offers products and services including Innovative Medicines, Generic Medicines, and Manufacturing Services.
- Headquarter Zurich, Switzerland
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Acino International Ag
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Latest Funding Round
-
Investors
ADQ
& 2 more
-
Employee Count
Employee Count
- Investments & Acquisitions
- Acquired by
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Acino
Acino offers a comprehensive portfolio of products and services, including Innovative Medicines, Generic Medicines, and Manufacturing Services.
Innovative medicines are developed for various health conditions.
Generic medicines are distributed to improve healthcare access.
Manufacturing services are provided for pharmaceutical product development.
People of Acino
Unlock access to complete
Human Resources and Administration
15 people
Finance and Accounting
11 people
Head Team
10 people
Software Development Team
9 people
Global Team
6 people
Sales and Marketing
5 people
Legal and Compliance
5 people
Leadership Team
3 people
Unlock access to complete
Funding Insights of Acino
Investors in Acino
Acino has secured backing from 3 investors, including venture fund and institutional investors. Prominent investors backing the company include ADQ, Nordic Capital and Avista Capital Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
ADQ is recognized as a leading sovereign investor focused on sustainable economic transformation in Abu Dhabi.
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location | |
|
Private equity investments are focused on the United States market.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Acino
Acino has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include M8 Pharmaceuticals.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Pharmaceutical company develop and commercialize leading original medicines
|
2007 |
Financial Statements - Acino
Acino Comparisons
Competitors of Acino
Latest news on Acino
Frequently Asked Questions about Acino
Acino was founded in 1836.
Acino is headquartered in Zurich, Switzerland.
Steffen Saltofte is the current CEO of Acino.
Acino is involved in the development, manufacturing, and marketing of innovative and generic medicines across various therapeutic areas. Operations are conducted in regions including Africa, Latin America, the Middle East, Türkiye, North Africa, Ukraine, and Eurasian countries. Advanced drug delivery systems are produced, focusing on dispersible and complex modified release formulations. Partnerships are established with global pharma companies for in-licensing and out-licensing of products. A commitment to sustainability and health matters is maintained through educational initiatives on conditions like hypertension and infectious diseases.
Acino offers Innovative Medicines, Generic Medicines, and Manufacturing Services.
Acino has made 1 acquisition, including M8 Pharmaceuticals.
Acino has 3 investors. Key investors include ADQ, Nordic Capital, and Avista Capital Partners.